Sarah Meneceur

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Combination Therapy

Histone Deacetylase

Top Venues

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Meneceur, Caroline E De Vos, Patrick Petzsch, Karl Köhrer, Guenter Niegisch, Michèle Janine Hoffmann
New synergistic combination therapy approaches with HDAC inhibitor quisinostat, cisplatin or PARP inhibitor talazoparib for urothelial carcinoma. Journal of cellular and molecular medicine 28 (9) (2024)
Sarah Meneceur, Caroline E De Vos, Patrick Petzsch, Karl Köhrer, Guenter Niegisch, Michèle Janine Hoffmann
New synergistic combination therapy approaches with HDAC inhibitor quisinostat, cisplatin or PARP inhibitor talazoparib for urothelial carcinoma. Journal of cellular and molecular medicine 28 (9) (2024)
Sarah Meneceur, Caroline E De Vos, Patrick Petzsch, Karl Köhrer, Guenter Niegisch, Michèle Janine Hoffmann
New synergistic combination therapy approaches with HDAC inhibitor quisinostat, cisplatin or PARP inhibitor talazoparib for urothelial carcinoma. Journal of cellular and molecular medicine 28 (9) (2024)
Sarah Meneceur, Caroline E De Vos, Patrick Petzsch, Karl Köhrer, Guenter Niegisch, Michèle Janine Hoffmann
New synergistic combination therapy approaches with HDAC inhibitor quisinostat, cisplatin or PARP inhibitor talazoparib for urothelial carcinoma. Journal of cellular and molecular medicine 28 (9) (2024)